France
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 134.79 B |
Feb. 3, 2025 | USD 107.52 | -0.55% |
|
France |
|
2 |
USD 836.74 M |
Feb. 3, 2025 | USD 70.72 | -3.82% |
|
France |
|
3 |
USD 478.51 M |
Feb. 3, 2025 | USD 16.08 | -1.36% |
|
France |
|
4 |
USD 446.66 M |
Feb. 3, 2025 | USD 2.75 | -2.79% |
|
France |
|
5 |
USD 380.91 M |
Feb. 3, 2025 | USD 6.01 | -3.90% |
|
France |
|
6 |
USD 267.83 M |
Feb. 3, 2025 | USD 26.71 | -2.67% |
|
France |
|
7 |
USD 227.67 M |
Feb. 3, 2025 | USD 2.39 | -1.03% |
|
France |
|
8 |
USD 165.51 M |
Feb. 3, 2025 | USD 3.49 | -3.73% |
|
France |
|
9 |
USD 152.35 M |
Feb. 3, 2025 | USD 1.82 | -2.26% |
|
France |
|
10 |
USD 143.57 M |
Feb. 3, 2025 | USD 6.56 | -7.03% |
|
France |
|
11 |
USD 98.26 M |
Feb. 3, 2025 | USD 1.52 | -5.09% |
|
France |
|
12 |
USD 90.48 M |
Feb. 3, 2025 | USD 5.78 | -4.67% |
|
France |
|
13 |
USD 86.69 M |
Jan. 31, 2025 | USD 4.22 | -0.94% |
|
France |
|
14 |
USD 44.62 M |
Feb. 3, 2025 | USD 0.63 | -4.33% |
|
France |
|
15 |
USD 40.37 M |
Feb. 3, 2025 | USD 2.96 | -10.54% |
|
France |
|
16 |
USD 32.05 M |
Feb. 3, 2025 | USD 3.50 | -2.33% |
|
France |
|
17 |
USD 22.82 M |
Feb. 3, 2025 | USD 1.45 | -1.30% |
|
France |
The Vaccines company in France with the highest Market Capitalization is Sanofi (Paris Stock Exchange: SAN.PA) at USD 134.79 B.
The Vaccines company in France with the lowest Market Capitalization is Valbiotis SA (Paris Stock Exchange: ALVAL.PA) at USD 22.82 M.
The top 10 Vaccines companies in France by Market Capitalization are Sanofi, Vetoquinol SA, MedinCell S.A., Valneva SE, ABIVAX SA, Eurobio Scientific SA, Inventiva S.A., Nanobiotix S.A., Innate Pharma S.A. and OSE Immunotherapeutics SA.
The bottom 10 Vaccines companies in France by Market Capitalization are Valbiotis SA, genOway SA, Aelis Farma SA, Novacyt S.A., DBV Technologies S.A., Adocia SA, AB Science S.A., OSE Immunotherapeutics SA, Innate Pharma S.A. and Nanobiotix S.A..